Drug-durg Interaction of SHR3680 With Digoxin, Rosuvastatin Calcium and Metformin Hydrochloride
NCT04621669 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 18
Last updated 2020-11-09
Summary
The DDI study had been designed to investigate the effect of SHR3680 on the pharmacokinetics of digoxin, Rosuvastatin calcium and metformin hydrochloride
Conditions
- Drug-drug Interaction,SHR3680
Interventions
- DRUG
-
SHR3680
240 mg
- DRUG
-
digoxin
0.25 mg
- DRUG
-
Rosuvastatin calcium
10 mg
- DRUG
-
metformin hydrochloride
500 mg
Sponsors & Collaborators
-
Jiangsu HengRui Medicine Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-11-19
- Primary Completion
- 2021-05-12
- Completion
- 2021-07-05
Countries
- China
Study Locations
More Related Trials
-
Drug-drug Interaction (DDI) Study of Spironolactone (Perpetrator) and Digoxin (Substrate Drug)
NCT03909529 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Effects of Savolitinib on the Pharmacokinetics of Digoxin, Rosuvastatin, Metformin, and Furosemide in Healthy Male Subjects
NCT05768360 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Effect of Dapagliflozin on the Pharmacokinetics of Warfarin or Digoxin in Healthy Subjects
NCT00904176 ·Status: COMPLETED ·Phase: PHASE1
-
Drug-durg Interaction of ZSP1273 With Digoxin, Rosuvastatin,Itraconazole and Probenecid
NCT05954624 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test Whether Zongertinib Influences the Amount of 4 Other Medicines (Dabigatran, Rosuvastatin, Metformin, and Furosemide) in the Blood
NCT06504862 ·Status: COMPLETED ·Phase: PHASE1
-
A Drug-Drug Interaction Study Between XW003 and Metformin, Warfarin, Rosuvastatin or Digoxin
NCT06335134 ·Status: COMPLETED ·Phase: PHASE1
-
A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LOXO-305) and Digoxin (P-Glycoprotein Substrate) in Healthy Participants
NCT06194214 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Effect of Povorcitinib on Digoxin, Rosuvastatin, and Metformin Pharmacokinetics and the Effect of Probenecid on Povorcitinib Pharmacokinetics When Administered Orally to Healthy Adult Participants
NCT06416800 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetic Study to Evaluate the Drug Interaction Between HRS5091 and Probe Drugs in Healthy Volunteers
NCT05273775 ·Status: COMPLETED ·Phase: PHASE1
-
Influence of Fedratinib on the Pharmacokinetics of the Transporter Probe Substrates Digoxin, Rosuvastatin, and Metformin
NCT04231435 ·Status: COMPLETED ·Phase: PHASE1
-
A Drug-Drug Interaction (DDI) Study of HDM1002 With Repaglinide, Atorvastatin, Digoxin and Rosuvastatin in Healthy Subjects and Overweight Subjects.
NCT06601517 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study to Evaluate the Drug-drug Interactions (DDIs) of IBI362 With Metformin, Warfarin, Atorvastatin, Digoxin in Overweight or Obese Subjects
NCT05815680 ·Status: COMPLETED ·Phase: PHASE1
-
Influence of HRS9531 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin in Healthy Subjects
NCT06723691 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy Adult Participants
NCT07223671 ·Status: COMPLETED ·Phase: PHASE1
-
A Drug-Drug Interaction Study Evaluating the Perpetrator Potential of DC-806 on Cocktails of CYP450 Enzyme and Transporter Substrates in Healthy Participants
NCT06092931 ·Status: COMPLETED ·Phase: PHASE1
-
Metformin and Furosemide Drug-Drug Interaction Study
NCT02028689 ·Status: COMPLETED ·Phase: PHASE1
-
A Drug Drug Interaction Study to Evaluate the Effect of VCT220 on the Pharmacokinetics of Repaglinide, Rosuvastatin, and Digoxin in Healthy, Overweight, and Obese Subjects
NCT07065058 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate The Effect of Pimicotinib on The Pharmacokinetics of Metformin, Fexofenadine and Rosuvastatin In Healthy Subjects
NCT06779253 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Clinical Study to Evaluate the Effects of SHR7280 on the Pharmacokinetics of Midazolam, S-warfarin, Omeprazole, Digoxin, and Rosuvastatin in Healthy Subjects
NCT06949124 ·Status: COMPLETED ·Phase: PHASE1
-
Drug-Drug Interaction Study of Evobrutinib and Transporter Substrates
NCT05064488 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Calderasib (MK-1084) With Midazolam and Digoxin in Healthy Participants (MK-1084-009)
NCT06575933 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Drug-drug Interactions (DDIs) of GP681 With Rosuvastatin, Digoxin, Itraconazole, Oseltamivir in Chinese Healthy Volunteers
NCT05789342 ·Status: COMPLETED ·Phase: PHASE1
-
This Study Tests the Effect of Certain Medicines on the Transport of Other Medicines in the Body of Healthy Men
NCT03307252 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetic Study to Evaluate the Drug Interaction Between SHR0302 and CYP Substrates in Healthy Volunteers
NCT05392127 ·Status: COMPLETED ·Phase: PHASE1
-
Drug Interaction Between SHR4640 Tablets and Furosemide Tablets in Healthy Volunteers (Single Center, Single Arm, Open, Self-control)
NCT04850638 ·Status: COMPLETED ·Phase: PHASE1